Kopetz S - Search Results

1

Lee WC, Kopetz S, Wistuba II, Zhang J. Lee WC, et al. Among authors: kopetz s. Ann Oncol. 2017 Sep 1;28(9):2045-2047. doi: 10.1093/annonc/mdx327. Ann Oncol. 2017. PMID: 28911075 Free article. No abstract available.

2

Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness.

Politano S, Overman M, Pathak P, Chadha R, Glover K, Chang DZ, Wolff RA, Hoff PM, Abbruzzese J, Eng C, Kopetz S. Politano S, et al. Among authors: kopetz s. Clin Colorectal Cancer. 2008 Jan;7(1):55-9. doi: 10.3816/CCC.2008.n.008. Clin Colorectal Cancer. 2008. PMID: 18279578

3

Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.

Kopetz S, Overman M, Chang DZ, Glover KY, Shureiqi I, Wolff RA, Abbruzzese JL, Eng C. Kopetz S, et al. J Clin Oncol. 2008 Apr 20;26(12):2000-5. doi: 10.1200/JCO.2007.13.2407. J Clin Oncol. 2008. PMID: 18421052

4

Adjuvant chemotherapy for stage II colon cancer.

Kopetz S, Freitas D, Calabrich AF, Hoff PM. Kopetz S, et al. Oncology (Williston Park). 2008 Mar;22(3):260-70; discussion 270, 273, 275. Oncology (Williston Park). 2008. PMID: 18494354 Free article. Review.

5

Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Kim MP, Park SI, Kopetz S, Gallick GE. Kim MP, et al. Among authors: kopetz s. Cell Tissue Res. 2009 Jan;335(1):249-59. doi: 10.1007/s00441-008-0682-9. Epub 2008 Sep 25. Cell Tissue Res. 2009. PMID: 18815812 Free PMC article. Review.

6

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Kesmodel SB, et al. Among authors: kopetz s. J Clin Oncol. 2008 Nov 10;26(32):5254-60. doi: 10.1200/JCO.2008.17.7857. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854565

7

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Kishi Y, et al. Among authors: kopetz s. Ann Surg Oncol. 2009 Mar;16(3):614-22. doi: 10.1245/s10434-008-0267-6. Epub 2009 Jan 8. Ann Surg Oncol. 2009. PMID: 19130139

8

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Kopetz S, et al. J Clin Oncol. 2009 Aug 1;27(22):3677-83. doi: 10.1200/JCO.2008.20.5278. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470929 Free PMC article.

9

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

Kopetz S, Hoff PM, Morris JS, Wolff RA, Eng C, Glover KY, Adinin R, Overman MJ, Valero V, Wen S, Lieu C, Yan S, Tran HT, Ellis LM, Abbruzzese JL, Heymach JV. Kopetz S, et al. J Clin Oncol. 2010 Jan 20;28(3):453-9. doi: 10.1200/JCO.2009.24.8252. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008624 Free PMC article. Clinical Trial.

10

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Overman MJ, et al. Among authors: kopetz s. J Clin Oncol. 2010 May 20;28(15):2549-55. doi: 10.1200/JCO.2009.27.5701. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters